Alireza Hosseini

Associate Professor

Laboratory Animal Science, MS


Lewis Hall

757.446.5634

hosseia@evms.edu


Dr. Hosseini received his M.D. degree from Hacettepe University, Faculty of Medicine, Ankara, Turkey. He practiced as General Practitioner in Ankara for 2 years before joining T.R. Lee Center for Ocular Pharmacology in the Department of Physiological Sciences at Eastern Virginia Medical School in Norfolk, VA for a post-doctoral fellowship in Pharmacology. During his post-doctoral and later as a faculty member and independent researcher, he has taught physiology and pharmacology in medical and graduate level courses and has worked in many pre-clinical research projects. His area of interest in ocular pharmacology research has been retinal angiogenesis and anterior chamber diseases. 

Faculty Appointments

Assitant Professor

School of Health Professions

Department of Physiological Sciences (secondary)

Department of Ophthalmology (tertiary)

Eastern Virginia Medical School

Norfolk, VA

 

 

Medical Education

Faculty of Medicine, Hacettepe University, Ankara, Turkey

Postdoctoral Education

Ocular Pharmacology, TR Lee Center for Ocular Pharmacology, Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, VA

Research Interests

Ocular Pharmacology

  • Retinal Angiogenesis
  • Anterior Chamber & Glaucoma

Presentations and Scholarships

Recent Peer Reviewed Publications:

Hosseini A, Lattanzio FA, Samudre SS, DiSandro G, Sheppard JD, Williams PB; Efficacy of a Phosphorodiamidate Morpholino Oligomer Antisense Compound in the Inhibition of Corneal Transplant Rejection in a Rat Cornea Transplant Model. J Ocul Pharmacol Ther. 2012 Apr; 28(2):194-201.

S Samudre, A Hosseini, F Lattanzio; Cannabinoids: a novel treatment for glaucoma. Acta Ophthalmologica, 2014 Sep; 92(s253)

Jacot JL, Looft-Wilson RC, Yousefieh N, Lattanzio FA, Hosseini A. The Vasoproliferative Phase in the Oxygen-Induced Rat Model of Retinopathy of Prematurity Exhibits Concomitant Increased Expression of VEGF164 and Phosphorylation of eNOS at Serine1179. J Clin Path Lab Med. 2017;1(1):12-20.

Complete Research Profile

https://researchers.evms.edu/display/person-alireza-hosseini

Faculty Appointments

Assitant Professor

School of Health Professions

Department of Physiological Sciences (secondary)

Department of Ophthalmology (tertiary)

Eastern Virginia Medical School

Norfolk, VA

 

 

Medical Education

Faculty of Medicine, Hacettepe University, Ankara, Turkey

Postdoctoral Education

Ocular Pharmacology, TR Lee Center for Ocular Pharmacology, Department of Physiological Sciences, Eastern Virginia Medical School, Norfolk, VA

Research Interests

Ocular Pharmacology

  • Retinal Angiogenesis
  • Anterior Chamber & Glaucoma

Presentations and Scholarships

Recent Peer Reviewed Publications:

Hosseini A, Lattanzio FA, Samudre SS, DiSandro G, Sheppard JD, Williams PB; Efficacy of a Phosphorodiamidate Morpholino Oligomer Antisense Compound in the Inhibition of Corneal Transplant Rejection in a Rat Cornea Transplant Model. J Ocul Pharmacol Ther. 2012 Apr; 28(2):194-201.

S Samudre, A Hosseini, F Lattanzio; Cannabinoids: a novel treatment for glaucoma. Acta Ophthalmologica, 2014 Sep; 92(s253)

Jacot JL, Looft-Wilson RC, Yousefieh N, Lattanzio FA, Hosseini A. The Vasoproliferative Phase in the Oxygen-Induced Rat Model of Retinopathy of Prematurity Exhibits Concomitant Increased Expression of VEGF164 and Phosphorylation of eNOS at Serine1179. J Clin Path Lab Med. 2017;1(1):12-20.

Complete Research Profile

https://researchers.evms.edu/display/person-alireza-hosseini
Submit a Profile Update